Limi®

Limi®

Therapeutic Segment: Antihyperglycemic

Generic Name: Glimepride + Metformin HCl

Indications:

For the management of patients with type 2 diabetes mellitus when diet, exercise and single agent
(glimepiride or metformin alone) do not result in adequate glycemic control.

Available as:             

Tablets
  • 1/500 mg
  • 2/500 mg                                                         PRESCRIBING INFORMATION